Navigation Links
Sinovac Participates in Two Investor Conferences in November
Date:10/27/2010

hese statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.Helen YangSinovac Biotech Ltd.Tel:  +86-10-8279-9871Fax:  +86-10-6296-6910Email: info@sinovac.com Investors:Stephanie Carrington/Amy GlynnThe Ruth GroupTel:  +1-646-536-7017/7023Email: scarrington@theruthgroup.comaglynn@theruthgroup.comMediaJason RandoThe Ruth GroupTel:  +1-646-536-7025Email:  jrando@theruthgroup.com
'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
2. Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
3. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
4. Sinovac Adjourns Annual General Meeting
5. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
6. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
7. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
8. Sinovac Biotech Holds 2007 Annual General Meeting
9. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
10. Sinovac to Participate in Two Upcoming Investor Conferences
11. Sinovac Named to Deloitte Technology Fast 50 China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MGB Biopharma at the ... MGB Biopharma, a biopharmaceutical company developing ... the major global problem of antibiotic resistance - ... (IV) formulation of MGB-BP-3, designed for the treatment of ... The intravenous formulation of MGB-BP-3 is currently in ...
(Date:6/1/2015)... 1, 2015  Turing Pharmaceuticals AG announced that life ... , MD, MSc,  has joined the company as ... Salinas, who holds a medical degree as well ... of significant accomplishments in the pharmaceutical industry, and ... Salinas has played a leadership role in numerous ...
(Date:6/1/2015)... CHICAGO , June 1, 2015 /PRNewswire/ ... robust Decipher® genomic analysis platform, successfully classified ... the genomic expression of certain biomarkers, including ... chemotherapy. Importantly, this unique genomic signature has ... responsiveness to neoadjuvant chemotherapy in patients with ...
(Date:6/1/2015)... June 1, 2015 Research ... addition of the "Global PDT Machine Industry ...        (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... is a professional and in-depth study on the ... report provides a basic overview of the industry ...
Breaking Biology Technology:MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Global PDT Machine Industry Report 2014 2
... cases from across the country to advance cancer care ... Inc ., the innovative healthcare company supporting the ... recognized as a Laureate by the International ... Program for its interactive patient management software ...
... Bulletin Board: RNER; "the Company"), which recently changed its ... new symbol to better reflect,its business. The new symbol: ... NASDAQ. , "The Company intends ... manufacturing business in China. The Company has,launched a new ...
... Infarction provided jointly by leading international cardiology societiesTOKYO ... Phase III TRITON-TIMI 38 study applied the new ... Infarction to the results of the study and ... undergoing percutaneous coronary intervention (PCI) and taking prasugrel, ...
Cached Biology Technology:US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 2US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 3US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 4US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 5RainEarth Inc. Changes Trading Symbol from GRKR to RNER 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... the atomic structure of a powerful "molecular motor" that ... during their assembly, an essential step in their ability ... researchers, from Purdue University and The Catholic University of ... motor works. Parts of the motor move in sequence ...
... Scientists have identified an initiating molecular mechanism in ... Cell Press in the December 26th issue of ... about generation of damaging amyloid β (Aβ) plaques ... of developing new preventative and disease-modifying therapies for ...
... that the human brainonce thought to be a seriously ... make the best decisions possible with the information we ... of the journal Neuron ., Neuroscientists Daniel Kahneman ... their 1979 research that argued humans rarely make rational ...
Cached Biology News:Biologists learn structure, mechanism of powerful 'molecular motor' in virus 2Biologists learn structure, mechanism of powerful 'molecular motor' in virus 3Impaired energy metabolism linked with initiation of plaques in Alzheimer's brain 2Our unconscious brain makes the best decisions possible 2Our unconscious brain makes the best decisions possible 3
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... Amplification Grade digests single- ... oligodeoxyribonucleotides. The specific activity ... I Amplification Grade is ... for absence of RNase ...
Biology Products: